ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Biologics in COPD: Why, when, and who"
Episode Synopsis
Dr. Jamie Rutland discusses the role of biologic therapy in COPD. He explains that type 2 inflammation, characterized by the presence of eosinophils, is a key factor in COPD. He also discusses the use of biologics to target this inflammation and reduce exacerbations in COPD patients.
Claim your 0.5 CME credits here: https://forms.gle/42yHmF8UpemVhdDJA
More episodes of the podcast The APAPP Podcast
Developing an APP run COPD Clinic
30/11/2025
AI in Lung Cancer Screening
31/10/2025
ILD in Scleroderma
30/09/2025
Advancing ILD & PH-ILD Care
21/09/2025
COPD Symposium Review
21/09/2025
In God we trust